TLX Annual Total Long Term Liabilities
$62.67 M
+$1.58 M+2.59%
01 December 2023
Summary:
As of January 21, 2025, TLX annual total long term liabilities is $62.67 million, with the most recent change of +$1.58 million (+2.59%) on December 1, 2023. During the last 3 years, it has risen by +$17.42 million (+38.50%). TLX annual total long term liabilities is now at all-time high.TLX Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TLX Quarterly Long Term Liabilities
$55.89 M
-$6.78 M-10.82%
01 June 2024
Summary:
As of January 21, 2025, TLX quarterly total long term liabilities is $55.89 million, with the most recent change of -$6.78 million (-10.82%) on June 1, 2024. Over the past year, it has stayed the same.TLX quarterly long term liabilities is now -10.82% below its all-time high of $62.67 million, reached on December 1, 2023.TLX Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TLX Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +2.6% | 0.0% |
| 3 y3 years | +38.5% | +27.0% |
| 5 y5 years | +471.7% | +264.5% |
TLX Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +24.1% | -10.8% | +27.0% |
| 5 y | 5-year | at high | +308.7% | -10.8% | +264.5% |
| alltime | all time | at high | >+9999.0% | -10.8% | >+9999.0% |
Telix Pharmaceuticals Limited Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | $55.89 M(-10.8%) |
| Dec 2023 | $62.67 M(+2.6%) | $62.67 M(+3.3%) |
| June 2023 | - | $60.67 M(-0.7%) |
| Dec 2022 | $61.08 M(+20.9%) | $61.08 M(+38.8%) |
| June 2022 | - | $44.02 M(-12.8%) |
| Dec 2021 | $50.51 M(+11.6%) | $50.51 M(+14.7%) |
| June 2021 | - | $44.05 M(-2.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2020 | $45.25 M(+195.1%) | $45.25 M(+119.8%) |
| June 2020 | - | $20.59 M(+34.3%) |
| Dec 2019 | $15.33 M(+39.9%) | $15.33 M(+41.8%) |
| June 2019 | - | $10.81 M(-1.4%) |
| Dec 2018 | $10.96 M(+4127.5%) | $10.96 M(+4256.8%) |
| June 2018 | - | $251.60 K |
| Dec 2017 | $259.30 K | - |
FAQ
- What is Telix Pharmaceuticals Limited annual total long term liabilities?
- What is the all time high annual total long term liabilities for Telix Pharmaceuticals Limited?
- What is Telix Pharmaceuticals Limited annual total long term liabilities year-on-year change?
- What is Telix Pharmaceuticals Limited quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Telix Pharmaceuticals Limited?
- What is Telix Pharmaceuticals Limited quarterly long term liabilities year-on-year change?
What is Telix Pharmaceuticals Limited annual total long term liabilities?
The current annual total long term liabilities of TLX is $62.67 M
What is the all time high annual total long term liabilities for Telix Pharmaceuticals Limited?
Telix Pharmaceuticals Limited all-time high annual total long term liabilities is $62.67 M
What is Telix Pharmaceuticals Limited annual total long term liabilities year-on-year change?
Over the past year, TLX annual total long term liabilities has changed by +$1.58 M (+2.59%)
What is Telix Pharmaceuticals Limited quarterly total long term liabilities?
The current quarterly long term liabilities of TLX is $55.89 M
What is the all time high quarterly long term liabilities for Telix Pharmaceuticals Limited?
Telix Pharmaceuticals Limited all-time high quarterly total long term liabilities is $62.67 M
What is Telix Pharmaceuticals Limited quarterly long term liabilities year-on-year change?
Over the past year, TLX quarterly total long term liabilities has changed by $0.00 (0.00%)